Porcine xenotransplantation in the clinical era: converging advances and unresolved barriers on the path to clinical translation - a narrative review - Takeaways - MDSpire

Porcine xenotransplantation in the clinical era: converging advances and unresolved barriers on the path to clinical translation - a narrative review

  • By

  • Douglas Henderson

  • Leonard Knoedler

  • Olivier Mathieu

  • Nathalie Rouas-Freiss

  • Curtis L. Cetrulo

  • Gilles Lemaitre

  • David M. Smadja

  • Nicolas O. Fortunel

  • Alexandre G. Lellouch

  • June 15, 2026

  • 0 min

Share

  • 1

    Porcine xenotransplantation offers a scalable alternative to human allotransplantation amid a global organ donor shortage.

  • 2

    Advancements in genetic modification and immunomodulation have improved graft survival and reduced rejection in porcine models.

  • 3

    Successful pig-to-human heart and kidney transplants have been achieved, demonstrating early clinical translation of porcine xenotransplantation.

  • 4

    Challenges such as antibody-mediated rejection and regulatory issues remain significant barriers to the widespread application of porcine xenotransplantation.

  • 5

    Complementary models, including pig-to-pig transplantation and human-to-pig chimerism, are being explored to enhance immune tolerance and graft compatibility.

Original Source(s)

Related Content